Association of Maternal Weight with FADS and ELOVL Genetic Variants and Fatty Acid Levels- The PREOBE Follow-up
Overview
Authors
Affiliations
Single nucleotide polymorphisms (SNPs) in the genes encoding the fatty acid desaturase (FADS) and elongase (ELOVL) enzymes affect long-chain polyunsaturated fatty acid (LC-PUFA) production. We aimed to determine if these SNPs are associated with body mass index (BMI) or affect fatty acids (FAs) in pregnant women. Participants (n = 180) from the PREOBE cohort were grouped according to pre-pregnancy BMI: normal-weight (BMI = 18.5-24.9, n = 88) and overweight/obese (BMI≥25, n = 92). Plasma samples were analyzed at 24 weeks of gestation to measure FA levels in the phospholipid fraction. Selected SNPs were genotyped (7 in FADS1, 5 in FADS2, 3 in ELOVL2 and 2 in ELOVL5). Minor allele carriers of rs174545, rs174546, rs174548 and rs174553 (FADS1), and rs1535 and rs174583 (FADS2) were nominally associated with an increased risk of having a BMI≥25. Only for the normal-weight group, minor allele carriers of rs174537, rs174545, rs174546, and rs174553 (FADS1) were negatively associated with AA:DGLA index. Normal-weight women who were minor allele carriers of FADS SNPs had lower levels of AA, AA:DGLA and AA:LA indexes, and higher levels of DGLA, compared to major homozygotes. Among minor allele carriers of FADS2 and ELOVL2 SNPs, overweight/obese women showed higher DHA:EPA index than the normal-weight group; however, they did not present higher DHA concentrations than the normal-weight women. In conclusion, minor allele carriers of FADS SNPs have an increased risk of obesity. Maternal weight changes the effect of genotype on FA levels. Only in the normal-weight group, minor allele carriers of FADS SNPs displayed reduced enzymatic activity and FA levels. This suggests that women with a BMI≥25 are less affected by FADS genetic variants in this regard. In the presence of FADS2 and ELOVL2 SNPs, overweight/obese women showed higher n-3 LC-PUFA production indexes than women with normal weight, but this was not enough to obtain a higher n-3 LC-PUFA concentration.
Rabehl M, Wei Z, Leineweber C, Enssle J, Rothe M, Jung A Front Nutr. 2024; 11:1356986.
PMID: 39021601 PMC: 11253720. DOI: 10.3389/fnut.2024.1356986.
Loukil I, Mutch D, Plourde M Genes Nutr. 2024; 19(1):11.
PMID: 38844860 PMC: 11157910. DOI: 10.1186/s12263-024-00747-4.
Abou Assi A, Heude B, Plancoulaine S, Sarte C, Tafflet M, Yuan W J Lipid Res. 2024; 65(6):100562.
PMID: 38762122 PMC: 11231547. DOI: 10.1016/j.jlr.2024.100562.
Zhang X, Cai Y, Jiang Y, Du W, An W, Fu Q Front Mol Biosci. 2024; 11:1368669.
PMID: 38577173 PMC: 10991826. DOI: 10.3389/fmolb.2024.1368669.
Gestational Weight Gain: Is the Role of Genetic Variants a Determinant? A Review.
Samano R, Martinez-Rojano H, Chico-Barba G, Gamboa R, Mendoza-Flores M, Robles-Alarcon F Int J Mol Sci. 2024; 25(5).
PMID: 38474283 PMC: 10932001. DOI: 10.3390/ijms25053039.